会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • POLYCLONAL ANTISERUM AGAINST A UNIVERSAL TUMOR ANTIGEN
    • 多普勒抗肿瘤抗肿瘤抗体
    • WO2006128715A2
    • 2006-12-07
    • PCT/EP2006/005269
    • 2006-06-02
    • WIDNES COMPANY INC.LUONGO, CÉSPEDES, Álvaro, JoaquinBATTISTONI SPINELLI, Julio, JoséLAMAS, ALFONSÍN, Alvaro, Luis
    • LUONGO, CÉSPEDES, Álvaro, JoaquinBATTISTONI SPINELLI, Julio, JoséLAMAS, ALFONSÍN, Alvaro, Luis
    • C07K16/30A61K39/395
    • C07K16/30A61K2039/505
    • The present invention relates to a polyclonal antiserum against a universal tumor antigen obtainable by (i) eliciting an in vivo humoral response against embryonic tissue in a non-human vertebrate, whereby said embryonic tissue is of the same genetic line as the non-human vertebrate; (ii) recovering from the immunized non-human animal spleen and isolating from said spleen individual spleen cells/lymphocytes; (iii) eliciting a second in vivo humoral response to the isolated spleen cells/lymphocytes suspension obtained in step (ii) in a further non-human animal of the same genetic line as the non-human animal of step (i); and (iv) isolating the desired polyclonal antiserum from said animal. Furthermore, the invention provides for the use of the polyclonal antiserum for the preparation of a pharmaceutical composition for the amelioration, prevention and/or treatment of cancer, in particular cancer of the breast, lung, prostate, uterus, colon, stomach or bladder. Additionally the invention relates to the use of the polyclonal serum of the invention for the preparation of a pharmaceutical composition, wherein said pharmaceutical composition is to be administered to a subject in need of treatment in combination with a further anti-proliferative drug or medicament.
    • 本发明涉及针对通用肿瘤抗原的多克隆抗血清,其可通过(i)在非人脊椎动物中引发针对胚胎组织的体内体液应答,由此所述胚胎组织具有与非人脊椎动物相同的遗传系 ; (ii)从免疫的非人动物脾脏中回收并从所述脾脏脾细胞/淋巴细胞中分离; (iii)在步骤(ii)中获得的分离的脾细胞/淋巴细胞悬浮液在与步骤(i)的非人动物相同遗传谱系的另一非人动物中引发第二体内体液应答; 和(iv)从所述动物中分离所需的多克隆抗血清。 此外,本发明提供多克隆抗血清用于制备用于改善,预防和/或治疗癌症,特别是乳腺癌,肺癌,前列腺癌,子宫癌,结肠癌,胃癌或膀胱癌的药物组合物的用途。 此外,本发明涉及本发明的多克隆血清用于制备药物组合物的用途,其中所述药物组合物将与需要治疗的受试者一起施用于另外的抗增殖药物或药物组合。